Clinical trial
Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in…
NCT00453154 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00453154 |
|---|---|
| Title | Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Official title | Combination Chemotherapy With or Without Maintenance Sunitinib Malate (NSC 736511) for Untreated Extensive Stage Small Cell Lung Cancer: A Phase IB/Randomized Phase II Study |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Extensive Stage Lung Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma |
| Intervention type | Drug, Other |
| Interventions | Carboplatin, Cisplatin, Etoposide, Laboratory Biomarker Analysis, Placebo Administration, Sunitinib Malate |
| Enrollment | 156 |
| Start date | Mar 15, 2007 |
| Primary completion | Jun 30, 2013 |
| Completion | Aug 20, 2015 |
| First posted | Mar 28, 2007 |
| Last update posted | Apr 4, 2023 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: